Objective: To compare a glucose test based on a standardized, designed breakfast to the 75-g oral glucose tolerance test (OGTT), comparing venous and capillary glucose values for the diagnosis of gestational diabetes mellitus (GDM). 
In the Western Cape Province of South Africa, the provincial guideline lists risk factors for GDM and directs selective screening 4 ; it offers two options for diagnostic testing. The first is a formal oral glucose tolerance test (OGTT) using 75-g of dextrose and recording fasting and 2-hour venous glucose values. However, the OGTT is unpleasant for patients and requires laboratory facilities. The alternate glucose profile is performed in the clinic and comprises a fasting capillary glucose measurement, consumption of a non-standardized glycemic load (the patient's breakfast) and a 2-hour capillary glucose measurement. The glucose profile is easy to perform and is regularly used at the Tygerberg Hospital, Cape Town, South Africa; however, a recent study found that the breakfast meals used varied widely in carbohydrate content.
5
This has provoked the search for a standardized, readily available, user-friendly, "designed breakfast". The aim of the present study was to compare the capillary glucose profile with a designed breakfast to the 75-g OGTT. The study was also designed to compare capillary samples obtained during the OGTT with laboratory measured plasma glucose levels.
| MATERIALS AND METHODS
The present prospective, randomized, cross-over study was performed at the High-Risk Antenatal Clinic at Tygerberg Hospital, Cape Town, South Africa, a secondary and tertiary referral center in the Western Cape Province of South Africa between March 1 and December 31, 2015. The patients recruited were not enrolled consecutively; they were eligible women present when the principal investigator was available in the clinic for the duration of tests.
Patients considered at high risk of developing GDM were recruited at the study clinic; the provincial guideline advocated selective screening and listed established risk factors for the development of GDM.
These included previous GDM, previous unexplained intra-uterine death, a previous macrosomic neonate with delivery weight heavier than 4.5 kg, a body mass index (calculated as weight in kilograms divided by the square of height in meters) above 40 at booking, maternal age over 40 years, a first-degree relative with diabetes, family origin with a high prevalence of diabetes (Asiatic), acanthosis nigricans, and polycystic ovarian syndrome. Patients with known pre-GDM and patients using chronic medication known to adversely affect glucose homeostasis were excluded from the study. Written A series of computer-generated random numbers, in blocks of ten, were placed in consecutive, opaque, sealed envelopes. Using these, patients were randomly allocated to undergo either an OGTT or a designed breakfast glucose profile (DBGP) at baseline; 1 week later, before any interventions (including dietary advice) were applied, the alternate test was performed in a crossover fashion with each patient acting as their own control. To limit any patient-initiated interventions, the results of the tests were not disclosed to the patient until both tests had been completed.
The OGTT was performed using a pre-measured 75 g of dextrose that was dissolved in water and ingested orally within 10 minutes. The present study was designed to recruit 50 patients; this number was determined by the nature of the study and the available resources, including the time constraints of the principal investigator (a trainee specialist).
Patient information and data were entered onto a spreadsheet using Excel version 2016 (Microsoft, Redmond, WA, USA) and statistical analyses was performed using SPSS version 24 (IBM, Armonk, NY, USA).
The Pearson correlation and intra-class correlation coefficients, using an absolute agreement definition, were calculated to assess relationships between variables and statistical significance was set at P<0.05.
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| RESULTS
All 58 patients who were approached consented to participate in the study. There were six patients lost to follow-up and one patient was excluded owing to a delay in performing the second diagnostic test
(an interim period of 14 days). No patients were excluded owing to a diagnosis of overt diabetes at the initial visit. Descriptive baseline data for the 51 patients included in the final study group are presented in Table 1 .
The screening risk factors that identified these patients as candidates for the diagnostic tests were: a body mass index (calculated as weight in kilograms divided by the square of height in meters) of at least 40 in 37 (73%) patients, previously unexplained intra-uterine death in 11 patients (22%), maternal age at least 40 years for 6 (12%)
patients, a first-degree relative with diabetes for 5 (10%) patients, and a previous macrosomic neonate of at least 4.5 kg for 4 (8%)
patients. More than one risk factor was present in 9 (18%) patients.
The median time interval between initial and cross-over testing was 7 days (range 5-9).
Correlations were made between OGTT venous and capillary measurements, as well as between the two modalities ( Figs 1 and 2 ).
Satisfactory correlations between the venous and capillary fasting and 2-hour OGTT values were demonstrated; correlations between capillary samples from the OGTT and the DBGP were less robust, but they were still statistically significant.
Although the primary outcomes were the correlations of glucose values from the tests, the diagnostic accuracy of the tests were also examined as exploratory outcomes among patients who had GDM threshold-meeting values for any of the tests used. The OGTT with venous sampling, and the OGTT and DBGP with capillary sampling identified GDM in five, six, and seven patients, respectively (Table 2) .
When considering the OGTT with venous sampling as the diagnostic gold standard, three patients with GDM were missed when using the DBGP and five false-positive results were recorded; however, three of the false positives were due to higher measured fasting capillary values (Table 2 ).
In keeping with the finding of a significant correlation between venous and capillary sampling ( When using the venous 2-hour OGTT as the gold standard, the 2-hour DBGP had 25% sensitivity, 96% specificity, 33% positive predictive value, and 94% negative predictive value. However, owing to small numbers of patients with positive test results, comparisons of the sensitivity and specificity are of limited value and any interpretation must be made with caution.
No patient had an HbA1c measurement that met the WHO diagnostic criteria for overt diabetes mellitus in non-pregnancy. Among patients who met the venous OGTT diagnostic criteria for GDM, the mean HbA1c value was 5.8% (range 5.5%-6.3%) ( Table 2 ).
| DISCUSSION
In the current environment of economic pressure and an obesity pandemic, the need for a pragmatic diagnostic modality is great. The present study compared the current "gold standard" OGTT with the DBGP, and demonstrated satisfactory correlation between capillary and venous samples within the OGTT and between the two modalities. F I G U R E 1 Illustration of the order the tests were compared.
Step There are few studies on GDM incidence and risk factors in Sub-Saharan Africa and heterogeneity is high. In the present study, the DBGP identified 7 (14%) patients with GDM in a study population considered to be at high risk of dysglycemia and where selective screening was mostly driven by obesity. In other studies with high-risk patients, the incidence of GDM has been estimated at 14%. 7, 8 The current incidence of GDM in South Africa is unknown.
F I G U R E 2 Scatter plots of comparisons between the fasting and 2-h values from venous and capillary OGTT and the DBGP. Venous OGTT vs capillary OGTT (A). Capillary OGTT vs capillary DBGP (B). Venous OGTT vs capillary DBGP (C).
Pearson correlation coefficients (r) and intraclass correlation coefficients (Intraclass) were used to limit bias. Abbreviations: OGTT, oral glucose tolerance test; DBGP, designed breakfast glucose profile. women with fasting plasma glucose levels of 5.8 mmol/L or less, and 2-hour glucose levels below 11.1 mmol/L after a 75-g oral glucose load. The study reported a strong correlation between increasing maternal glucose levels at 24-32 weeks of pregnancy and a range of adverse maternal and fetal outcomes. No specific plasma glucose value above which the risk of adverse pregnancy outcomes was markedly increased was identified; instead, the study revealed a continuum of risk with increasing maternal glucose levels. Consequently, diagnostic criteria are necessarily arbitrary cut-offs based on an odds ratio for adverse outcomes. Two large randomized intervention studies 9, 10 confirmed the observations of the HAPO trial by demonstrating the benefits of treatment for both mother and fetus at mild glucose elevations in later gestation. Lifestyle modification formed the basis of therapy in both studies, with pharmacologic interventions only required in a minority of study patients. In the present study, the difference between "positive" and "negative" values were mostly small and the focus should therefore be on the range of values rather than absolute diagnostic cut-offs. Rather, this could be interpreted as inherent inter-test variability.
The danger of missed treatment opportunities balanced with the cost of over diagnosis of GDM must also be considered. Correct diagnosis and timely intervention helps optimize maternal and fetal outcomes. Point-of-care results for diagnosis and management, using capillary sampling either as part of the OGTT or DBGP, eliminate the need for laboratory equipment and staff, expenses related to transportation (and potential loss of income), and the need for additional visits.
Limitations of the present study included the small sample size, the resultant low GDM rate, and that no formal cost analysis was performed. Although study patients were specifically instructed not to make any dietary adaptations in the 1-week interval between tests, the possibility of patient-initiated dietary changes cannot be ruled out with absolute certainty.
The study population in the present study was too small to draw firm conclusions but the more palatable designed meal demonstrated a statistically significant correlation with the gold standard OGTT for the diagnosis of GDM; therefore, this should be investigated further as an alternate test with merits.
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